TSBX Profile
Turnstone Biologics Corp., headquartered in La Jolla, California, is a dynamic clinical stage biotechnology company dedicated to pioneering innovative treatments for patients suffering from solid tumors. Established in 2014, Turnstone Biologics focuses on advancing a robust pipeline of therapeutic candidates designed to effectively treat and potentially cure various types of cancers. At the forefront of its portfolio is TIDAL-01, the company's lead product currently undergoing Phase 1 clinical trials. These trials aim to evaluate its efficacy in treating breast cancer, colorectal cancer, uveal melanoma, and other forms of melanoma through an investigator sponsored trial.
In addition to TIDAL-01, Turnstone Biologics is actively developing TIDAL-02, which is currently in preclinical stages. This promising candidate is designed to target solid tumors, further underscoring the company's commitment to expanding treatment options for cancer patients. Turnstone Biologics leverages cutting-edge research and development methodologies to advance its therapeutic platforms, with a focus on harnessing the immune system's capabilities to combat malignancies.
Beyond its innovative pipeline, Turnstone Biologics collaborates extensively with leading academic institutions, research centers, and pharmaceutical partners to accelerate the development and commercialization of its therapies. This collaborative approach enhances the company's ability to explore novel treatment modalities and optimize therapeutic outcomes. Turnstone Biologics' strategic initiatives also include exploring potential combination therapies and expanding the applications of its technologies across diverse oncological indications.
Driven by a mission to transform cancer treatment paradigms, Turnstone Biologics remains committed to delivering groundbreaking therapies that address critical unmet medical needs. With a multidisciplinary team of scientists, clinicians, and industry experts, the company continues to push the boundaries of biotechnology innovation. By fostering a culture of scientific excellence and strategic growth, Turnstone Biologics is poised to make significant advancements in the fight against cancer, offering hope to patients and healthcare providers worldwide.
|
